Can neurotoxic metals and gadolinium promote autoantibody formation through oxidative injury?

In an 83-year-old, this proposed pathway is biologically coherent but should be separated into well-supported toxicology findings and later immune steps that remain unproven clinically.

Metals: oxidative stress and cellular injury

• Lead, mercury, cadmium, and arsenic can disrupt antioxidant defenses, increase reactive oxygen species, and produce oxidative damage. Experimental evidence also supports associated cellular and neuronal injury.
• Relevant oxidative-stress measures include altered glutathione balance, lipid-peroxidation products, antioxidant-enzyme activity, protein carbonyls, and urinary 8-OHdG. These biomarkers are nonspecific and do not establish neural injury on their own.
• Human epidemiology is less consistent for particular neurologic outcomes; thus, established metal-related oxidative toxicity does not itself demonstrate a defined autoimmune neurologic consequence.

Gadolinium

• Repeated gadolinium-based contrast-agent exposure is established to produce brain gadolinium retention, including in people with normal renal function. Deposition is generally greater with less-stable linear agents, though lower-level retention has also been reported with macrocyclic agents.
• Oxidative stress and cellular injury from retained gadolinium are credible toxicological mechanisms, but human evidence has not demonstrated that brain retention causes oxidative injury, neural-cell injury, neurologic symptoms, or clinical harm.

Neural antigens and autoantibodies

• Injury could expose normally sequestered neural antigens, allowing immune presentation. In lead- and mercury-exposed rodents, antibodies to neuronal neurofilaments and myelin basic protein tracked with exposure; astrogliosis and nervous-system injury were also reported.
• These models support an exposure-associated neuroinflammatory/autoantibody phenotype. Mercury models additionally implicate T-cell-help-dependent systemic autoimmunity. They do not establish that neural-antigen release sustains specific autoantibodies in exposed humans.

Bottom line

• The claim is plausible overall: metal-induced oxidative stress and injury are well grounded; gadolinium-related injury and the progression from neural injury to persistent human autoantibody formation remain mechanistically credible rather than clinically demonstrated.